Yubo International Biotech Ltd (YBGJ) stock
YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.01+0.00 (0.00%)
Close on Oct 16, 2026Market cap $886.19KP/E –Yield –
Yubo International Biotech gross margin
Gross margin is gross profit as a percentage of revenue.
Yubo International Biotech's gross margin for the twelve months ending Jun 30, 2026 was 66.1%. For fiscal 2026 it was 66.1%, against 76.3% the year before. The highest annual figure on record is 76.3% in fiscal 2025.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Dec 31, 2025 | 66.1% | −10.2 |
| FY2025 | Dec 31, 2024 | 76.3% | +7.0 |
| FY2024 | Dec 31, 2023 | 69.3% | +18.8 |
| FY2023 | Dec 31, 2022 | 50.5% | −15.5 |
| FY2022 | Dec 31, 2021 | 65.9% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2026CQ4 2025 | Dec 31, 2025 | 66.1% | +4.2 |
| Q1 FY2025CQ1 2024 | Mar 31, 2024 | 76.3% | +39.5 |
| Q4 FY2024CQ4 2023 | Dec 31, 2023 | 81.0% | +37.5 |
| Q3 FY2024CQ3 2023 | Sep 30, 2023 | 80.3% | +14.5 |
| Q2 FY2024CQ2 2023 | Jun 30, 2023 | 61.9% | −11.5 |
| Q1 FY2024CQ1 2023 | Mar 31, 2023 | 36.8% | −17.5 |
| Q4 FY2023CQ4 2022 | Dec 31, 2022 | 43.5% | −22.4 |
| Q3 FY2023CQ3 2022 | Sep 30, 2022 | 65.8% | −8.6 |
| Q2 FY2023CQ2 2022 | Jun 30, 2022 | 73.4% | – |
| Q1 FY2023CQ1 2022 | Mar 31, 2022 | 54.3% | – |
| Q4 FY2022CQ4 2021 | Dec 31, 2021 | 65.9% | – |
| Q3 FY2022CQ3 2021 | Sep 30, 2021 | 74.5% | – |
See a number that looks wrong?